Molecular Targets and Cancer Therapeutics 2011: Interview with Daniel R. Rhodes, Ph.D., chief executive officer, Compendia Bioscience
Dr. Rhodes discusses his strategy for identifying novel targets and for generating new opportunities for existing targeted therapies and the potential for genomic-based tumor characterization.
* the mp4 of the video (110.38 MB; 05:08 Min.)
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.
Updated: Nov. 15, 2011